Article
Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan.
Cancer letters - 5 Dec 2002
Yoneda Kohri, Tanji Yoshio, Ikeda Noriko, Miyoshi Yasuo, Taguchi Tetsuya, Tamaki Yasuhiro, Noguchi Shinzaburo
Abstract excerpt
The effect of adjuvant tamoxifen treatment on bone mineral density (BMD) and bone turnover markers was studied in postmenopausal breast cancer patients. The relationship of tamoxifen's effect with the genetic polymorphisms of estrogen receptor (ER)-alpha and ER-beta gene was also studied. Twenty-one postmenopausal breast cancer patients were given tamoxifen (20 mg/day) as the adjuvant treatment after the surgery....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
